Side-by-side comparison of AI visibility scores, market position, and capabilities
World's largest insurance broker network (Marsh, Guy Carpenter, Mercer, Oliver Wyman); $23.4B FY2024 revenue; hard market tailwind 2019-2024; cyber insurance leader; competes with Aon, Willis Towers Watson.
Marsh McLennan is the world's leading professional services firm in risk, strategy, and human resources, formed through the merger of Marsh & McLennan Companies and operating four market-leading subsidiaries: Marsh (global insurance broker and risk management advisor), Guy Carpenter (global reinsurance broker), Mercer (human resources and employee benefits consulting), and Oliver Wyman (management consulting). Headquartered in New York City and trading on NYSE (MMC), the company generated approximately $23.4 billion in revenues for FY2024 under CEO John Doyle, who succeeded longtime CEO Dan Glaser in 2022 and has maintained the firm's organic growth momentum and selective acquisition strategy. Marsh, the flagship insurance brokerage, is the world's largest insurance broker by revenue, advising corporations globally on risk placement, captive insurance programs, and risk management strategies across property, casualty, marine, and specialty lines.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.